Back to search

Institutional Repository of Vilnius University

Pacientų, kuriems įtariama ūminė promielocitinė leukemija, blastų biožymenų raiškos ypatumai /

Abstract

dc:description

The objective of the study – is to determine the most characteristic of acute promyelocytic leukemia blasts biomarker expression features. To achieve this objective there has been assigned the following tasks: Applying Flow cytometry method to find out the most typical promyelocytic leukemia immunophenotype markers; identify the most typical blast immunophenotype of acute promyelocytic leukemia; identify the most sensitive and most specific immunophenotype for acute promyeloytic leukemia To fulfill the Objective and Tasks we examined 64 patients who were suspected of acute promyelocytic leukemia. All of these individuals have been treated in Santariškės Vilnius University Hospital Department of Hematology in years 2008-2015. This study analyzed patient`s data such as gender, age, complete blood count. Extremely important for the study was patient`s data: blast biomarkers expression - assesed by a flow cytometer, cytomorphological patient`s bone marrow or peripheral blood analysis and molecular genetics data on presence or absence of mutations, which have resulted in acute promyelocytic leukemia. The obtained results showed that for acute promyelocytic leukemia the most typical biomarkers combinations are: a negative HLA-DR, CD34 biomarkers expression, low CD56 marker expression, positive CD117 marker expression and high CD64 sign expression at mutations between 15 and 17 chromosomes couples; research has revealed 4 typical acute promyelocytic leukemia immunofenotypes: SSC-h / CD34- / CD117 + b / CD33 ++ / CD13 + h / CD2- / CD56- / CD64 + / CD15 + b / HLA-DR-; SSC-h / CD34- / CD117 + b / CD33 ++ / CD13 ++ / CD2- / CD56- / CD64 + / CD15 + b / HLA-DR-; SSC-h / CD34- / CD117 + / CD33 + / CD13 + / CD2 + b / CD56- / CD64 + b / CD15 + b / HLA-DR-; SSC-H / CD34- / CD117 + / CD33 ++ / CD13 ++ / CD2 + b / CD56- / CD64 + / CD15- / HLA-DR-; the most sensitive phenotypes of them were SSC-h / CD34- / CD117 + b / CD33 ++ / CD13 + h / CD2- / CD56- / CD64 + / CD15 + b / HLA-DR-; SSC-h / CD34- / CD117+ b / CD33 ++ / CD13 ++ / CD2- / CD56- / CD64 + / CD15 + b / HLA-DR- and SSC-H / CD34- / CD117 + / CD33 ++ / CD13 ++ / CD2 + b / CD56 - / CD64 + / CD15- / HLA-DR-.

Degree

thesis:*
Grantor dc:publisher
Institutional Repository of Vilnius University
Year dc:date
2016

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Poškutė, Aistė,
Contributors dc:contributor
  • Matuzevičienė, Rėda

Rights

dc:rights
Statement dc:rights
  • info:eu-repo/semantics/openAccess
Language dc:language
lit

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
Vilnius University
Base URL
epublications.vu.lt/oai
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Poškutė, Aistė,. Pacientų, kuriems įtariama ūminė promielocitinė leukemija, blastų biožymenų raiškos ypatumai /. Institutional Repository of Vilnius University, 2016. https://repository.vu.lt/VU:ELABAETD20295885&prefLang=en_US